/f/288104308443570/4176x1488/9aa7ce1087/ki-web.png)
AI for Clinical Routine Tasks
We are looking for solutions that take over documentation, medical report writing, and coding via AI, data-sovereignly on the hospital's own infrastructure, so that doctors can treat instead of type.
AI for Clinical Routine Tasks
We are looking for solutions that take over documentation, medical report writing, and coding via AI, data-sovereignly on the hospital's own infrastructure, so that doctors can treat instead of type.
Key Challenge Partner
Our hub partner UKGM wants to noticeably relieve medical staff from routine tasks. A significant portion of medical working time currently flows into documentation, medical report writing, and coding, which consequently leaves less time for patients. Where verified alternatives are lacking, external AI tools fill the gap, and the goal is to make this shadow AI obsolete through a secure, hospital-owned solution.
Final Blueprint
An AI creates draft medical reports, documentation, and coding suggestions directly from the treatment context. It runs locally on the hospital infrastructure, entirely without data leakage. Doctors review the results and approve them.
Industry Bottlenecks
High administrative workload due to documentation obligations.
Cloud LLMs are not approved for patient data.
Strict medical device law slows down new solutions.
Why founders choose LOVEDIS
Our ecosystem gives you real connections, lab space, and industrial infrastructure to test what you’ve built. We bridge the gap between ideas and implementation so you can grow faster and with less risk.
Direct access to industry
Work with partners who open doors to infrastructure, expertise, and real use cases, accelerating your path toward market readiness.
Access to real resources
Labs, workshops, machinery, network, data, and operational setups - it’s all here. Use what you need to validate and scale faster.
Equity-Free & Zero Cost
Our program is free of charge, and we take no equity.
Tailored 1-to-1 support
No copy-paste coaching. Individual mentoring and support that makes real progress possible.
Application form
Apply now
Applications close on May 3, 2026
Any questions?
If you have any questions or need clarification, please reach out directly to our Venture & Innovation Manager, Polina.
/f/288104308443570/3393x3399/21f8af7c71/polina-kon-lovedis.png)
Challenges in Health Tech
Haven’t found the right fit yet? Explore more of our health tech challenges below.
/f/288104308443570/1634x1956/d6afffeb9c/challenge1.png)
Digital Initial Assessment and Patient Steering
We are looking for solutions that digitally capture patients even before their hospital visit, assess them medically, and route them systematically into the appropriate care structure.
FAQs
Find answers to the most common questions about our program and application process.
No. Participation in LOVEDIS is free for startups — including access to infrastructures, expert teams, and program resources.
Our program is two-tiered and results-driven. All teams begin with the three-month Base Accelerator. High-performing teams then qualify for the subsequent 1:1 Accelerator, where we spend an additional three months working intensively and individually on your scaling strategy.
Yes — if you are a tech startup with a prototype or MVP and a clear goal to validate or scale together with industry partners.
The Base Accelerator works well in a hybrid format. The 1:1 Accelerator includes on-site phases with our hub partners to validate and develop your solution in real environments.
We focus on teams beyond the pure idea stage. You should have a prototype, MVP, or early product that can be tested, validated, and further developed with partners.
No. Incorporation is not required for application. A GmbH or similar structure is helpful later — but not a condition to enter the program.
Yes. We welcome European and international teams — as long as they’re willing to collaborate with our industry and hub partners.
We focus on technologies with strong industrial relevance, particularly in LifeScience, Construction, and Industry & Automation. Cross-industry solutions are explicitly welcome.
No — LOVEDIS does not take equity.